-
Subject Areas on Research
-
A Touchy Subject: Can Physicians Improve Value by Discussing Costs and Clinical Benefits With Patients?
-
ACA Marketplace premiums and competition among hospitals and physician practices.
-
Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.
-
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
-
Clinician-patient E-mail communication: challenges for reimbursement.
-
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
-
Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.
-
Copayment reductions generate greater medication adherence in targeted patients.
-
Cost-sharing requirements and access to mental health care among medicare enrollees with schizophrenia.
-
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.
-
Effect of switching to a high-deductible health plan on use of chronic medications.
-
Employee demand for health insurance and employer health plan choices.
-
Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder.
-
Factors associated with enrollment, satisfaction, and sustainability of the New Cooperative Medical Scheme program in six study areas in rural Beijing.
-
From physician to consumer: the effectiveness of strategies to manage health care utilization.
-
How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives.
-
How price responsive is the demand for specialty care?
-
Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
-
Low-socioeconomic-status enrollees in high-deductible plans reduced high-severity emergency care.
-
Managing marketplaces requires state regulators to make tough choices.
-
Overcoming barriers to discussing out-of-pocket costs with patients.
-
Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?
-
Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
-
Payments, promotion, and the purple pill
-
Pricing and Welfare in Health Plan Choice.
-
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.
-
Reduced Cost-sharing for Preventive Drugs Preferentially Benefits Low-income Patients With Diabetes in High Deductible Health Plans With Health Savings Accounts.
-
Relationship between occurrence of surgical complications and hospital finances.
-
Rural health prepayment schemes in China: towards a more active role for government.
-
Rural-Urban Differences In Individual-Market Health Plan Affordability After Subsidy Payment Cuts.
-
Terminating Cost-Sharing Reduction Subsidy Payments: The Impact Of Marketplace Zero-Dollar Premium Plans On Enrollment.
-
The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial.
-
The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?
-
The differential effect of compensation structures on the likelihood that firms accept new patients by insurance type.
-
The effect of heavy drinking on social security old-age and survivors insurance contributions and benefits.
-
The relationship between insurance coverage and psychiatric disorder in predicting use of mental health services.
-
User fees for health services. Norwegian perspective on copayments.
-
Value-based insurance design program in north Carolina increased medication adherence but was not cost neutral.
-
Value-based insurance design: quality improvement but no cost savings.
-
Value-based insurance design: the authors reply.